FDA PHARMA today FDA PHARMA to Saturday December 16th, 2017By Tokio X'press EMA, Pharmaceutical kyowa-kirin, Takeda FDA PHARMA to
Kyowa Hakko Kirin, anti-Ccr4 humanized antibody acceptance application for European approval of Mogum Lysumab 20171027 Kyowa Hakko K Friday October 27th, 2017By Tokio X'press EMA, Pharmaceutical kyowa-kirin Kyowa Hakko K
FDA PHARMA TODAY
FDA PHARMA today